MS vs IVZ
By Alex · Tickerpine
Morgan Stanley vs Invesco Ltd., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MS | IVZ |
|---|---|---|
| Price | $217.64 | $31.54 |
| Market cap | $342.13B | $13.92B |
| P/E ratio | 17.4 | — |
| ROE | 17.97% | -0.57% |
| Profit margin | 25.90% | -0.93% |
| Revenue growth | 28.00% | 20.50% |
| Dividend yield | 2.14% | 2.73% |
| Beta | 1.21 | 1.60 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MS vs IVZ in plain English
- MS is the bigger company — about 24.6× the market cap of IVZ.
- MS earns a higher return on equity (18% vs -1%).
- MS is growing revenue faster (28% vs 20%).
- IVZ has the higher dividend yield (2.73% vs 2.14%).
How would $1,000 have done in each?
MS return calculator
See what $1,000 in Morgan Stanley would be worth today.
IVZ return calculator
See what $1,000 in Invesco Ltd. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.